Narrative review / 1995
Androgen excess in women is linked to risks such as cardiovascular disease and insulin resistance, with risk reduction including weight maintenance and exercise.
This review details the clinical manifestations and health risks of androgen excess in women, including hirsutism, central obesity, cardiovascular disease, intravascular thrombosis, and insulin resistance. It highlights that prompt recognition and an interdisciplinary approach can reduce associated morbidity and mortality. Recommended risk reduction strategies encompass maintaining ideal weight, exercise, smoking cessation, treating dyslipidemias, low-dose aspirin, and appropriate hormone therapies.
- Study type
- Narrative review
- Who was studied
- Women with androgen excess
- What was measured
- Health risks and management strategies of androgen excess
THE PAPER
Effects of sex steroids on women's health: implications for practitioners.
Derman RJ. Am J Med, 1995.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.